ArticleFrontiers in oncology2021

Preclinical Characterization of GLS-010 (Zimberelimab), a Novel Fully Human Anti-PD-1 Therapeutic Monoclonal Antibody for Cancer.

Beilei Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.